Insiders / Reardon Andrew

Reardon Andrew

CIK 1950232personinsider
Companies
1
First seen
Feb 18, 2026
Last activity
Mar 27, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Ligand Pharmaceuticals Inc · LGNDExecutive36,86954,44422

All securities held

2 positions · latest reported per filing
CompanySecuritySharesAs of
Ligand Pharmaceuticals IncCommon Stock36,869Mar 4, 2026
Ligand Pharmaceuticals IncEmployee Stock Option (right to buy)Derivative54,444Mar 4, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Feb 14, 2026OtherLGND
Ligand Pharmaceuticals Inc
Common Stock
$750.6K-4K
-9.42%
39,255
0.20% of shares
low
Feb 14, 2026OtherLGND
Ligand Pharmaceuticals Inc
Common Stock
$590.3K-3K
-8.51%
34,528
0.17% of shares
low
Mar 4, 2026SellLGND
Ligand Pharmaceuticals Inc
Common Stock
$300.9K-1K
-3.66%
38,011
0.19% of shares
medium
Mar 4, 2026ExerciseLGND
Ligand Pharmaceuticals Inc
Common Stock
$261.4K+5K
+13.56%
41,869
0.21% of shares
low
Mar 4, 2026SellLGND
Ligand Pharmaceuticals Inc
Common Stock
$238.5K-1K
-3.00%
36,869
0.18% of shares
medium
Feb 15, 2026OtherLGND
Ligand Pharmaceuticals Inc
Common Stock
$182.4K-992
-2.62%
36,869
0.18% of shares
low
Feb 15, 2026OtherLGND
Ligand Pharmaceuticals Inc
Common Stock
$147.2K-801
-2.07%
37,861
0.19% of shares
low
Mar 4, 2026SellLGND
Ligand Pharmaceuticals Inc
Common Stock
$126.7K-612
-1.53%
39,457
0.20% of shares
medium
Feb 15, 2026OtherLGND
Ligand Pharmaceuticals Inc
Common Stock
$109.0K-593
-1.51%
38,662
0.19% of shares
low
Mar 4, 2026SellLGND
Ligand Pharmaceuticals Inc
Common Stock
$94.4K-460
-1.13%
40,409
0.20% of shares
low